Commentary · 8 Jun 2026
Mini reviewPublished 31 May 2021
Naturido Could Modulate Glia-Neuron Interactions
1Biococoon Laboratories, Inc., Ueda, Morioka, Japan; 2Graduate School of Science, Osaka City University, Osaka, Japan; 3Department of Aging Science and Pharmacology, Kyushu University, Fukuoka, Japan; 4DBT Research Center, Kyushu University, Fukuoka, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Our groups recently published that a novel cyclic peptide (Naturido) modulates glia-neuron interactions in vitro and reverses aging-related deficits in senescence-accelerated mice. This article suggests that Naturido is a promising glia-neuron modulator for the treatment of not only senescence, but also Alzheimer’s disease (AD) and other neurodegenerative disorders. We briefly review the main points of this article.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Alzheimers Disease & Parkinsonism.
Perspective · 8 Jun 2026
Oxidative Stress and Its Role in Neuronal Degeneration: Mechanisms and Implications
Commentary · 8 Jun 2026
Understanding the Pathophysiology of Prion-Induced Dementia
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Alzheimers Disease & Parkinsonism
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Koichi Suzuki”
- BylineArticles whose byline prints “Tetsuro Shinada”
- BylineArticles whose byline prints “Zhou Wu”
